InsidersTradesSigma
Jasper Therapeutics, Inc.: directors' dealings · United States · SEC (Form 4)
SEC:jasper-therapeutics-inc-42e7a6US·SEC (Form 4)Mcap 22M€Healthcare
Explore the full insider trade history of Jasper Therapeutics, Inc., a publicly traded company based in United States. Shares trade on US US, under the authority of SEC (Form 4). Operating in the Healthcare sector, Jasper Therapeutics, Inc. has recorded 2 reports. Market capitalisation: €22m. The latest transaction was disclosed on 28 June 2022 — Cession. Among the most active insiders: Lis William. The full history is free.
2
Insider Decl.
0
Thresholds
·
0 ops.
Buy Volume
€47,557
1 ops.
Sell Volume
Financial data
FY ended December 2025 · cache
0.79 €
Analyst consensus
5 analystsBuy
1.50 €Target 7.50 €(+854%)20.00 €
Income statement
Net income−75.8 M€0.0% margin
Valuation
PER (forward)-0.4x
P/Book5.3x
Balance sheet & cash
Market cap22.0 M€
Total debt1.2 M€
Free Cash Flow−77.2 M€
Debt / Equity22%
Profitability & ownership
ROE-244.2%
ROA-112.2%
% insiders1.2%
% institutions60.6%
Last declaration on 28 June 2022
Declarations0 total
No declarations found
0 of 0 declarations